World Model · podcast knowledge graph

#525: Multi-Cancer Early Detection Testing

2026-05-18 · 46 min · 15 entities

episode page audio

Asserted relationships

Entities found in this episode

concepts 9

  • mentioned Education concept
    0.50
    evidence rules-v5
    Feed category: Education
  • mentioned Science concept
    0.50
    evidence rules-v5
    Feed category: Science
  • mentioned Health & Fitness concept
    0.50
    evidence rules-v5
    Feed category: Health & Fitness
  • mentioned Higher Education concept
    0.50
    evidence rules-v5
    Feed category: Higher Education
  • 0.42
    evidence rules-v5
    #525: Multi-Cancer Early Detection Testing
  • discusses Education concept
    0.40
    evidence rules-v5
    Feed category: Education
  • discusses Science concept
    0.40
    evidence rules-v5
    Feed category: Science
  • discusses Health & Fitness concept
    0.40
    evidence rules-v5
    Feed category: Health & Fitness
  • discusses Higher Education concept
    0.40
    evidence rules-v5
    Feed category: Higher Education

persons 2

  • mentioned Matthew Watto MD person
    0.86
    evidence rules-v5
    Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP
  • mentioned Margaret Tempero person
    0.86
    evidence rules-v5
    Guest: Margaret Tempero, MD

podcasts 2

websites 2

  • mentioned Medicine website
    0.50
    evidence rules-v5
    Feed category: Medicine
  • discusses Medicine website
    0.40
    evidence rules-v5
    Feed category: Medicine
Episode description as stored
Cut through the hype of Multi-Cancer Early Detection (MCED) tests and learn how to counsel patients on the real-world utility, false-positive risks, and the "stage shift" debate of these emerging blood assays. We are joined by world-renowned oncologist Dr. Margaret Tempero , UCSF Cancer Early Detection and Interception , to discuss whether these tests are truly ready for clinical prime time. Claim CME for this episode at curbsiders.vcuhealth.org ! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments 00:00 Introduction  01:57 Current Cancer Screening Programs  06:05 Emerging Blood-Based Cancer Tests  11:55 Test Characteristics and Limitations  18:05 Practical Considerations for Patients  25:33 Direct-to-Consumer Testing/Whole Body MRIs 36:46 Navigating Positive Test Results  45:10 Anxiety and Patient Education  47:08 Future Directions in Cancer Screening  Outro Credits Producer, Writer, Show Notes, Infographic, Cover Art: Molly Heublein MD Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Reviewer: Sai S Achi MD,MBA,FACP Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Margaret Tempero, MD Disclosures Dr. Tempero reports the following financial relationships: Grail (research support), Global Bio Access Fund (Advisor), Bristol Myers Squibb (Membership on Advisory Committees or Review Panels, Board Membership, etc.), Astra Zeneca (Membership on Advisory Committees or Review Panels, Board Membership, etc), Immunovia (Membership on Advisory Committees or Review Panels, Board Membership, etc.), Merck (advisory committee), Renovo Rx (advisory committee), Urogen (Advisor). Financial relationships have not ended. The Curbsiders report no relevant financial disclosures.  Sponsor: FIGS   Curbsiders listeners can get 15% off. Just go to WearFIGS.com and use code FIGSRX.   Sponsor: Freed Try Freed Front Desk free for 7 days at getfreed.ai/front-desk . Sponsor: Quince  Go to Quince.com/curb for free shipping on your order  and 365-day returns. Now available in Canada, too.